- Home
- LCFY vs ITOC Comparison
LCFY vs ITOC Comparison
Compare LCFY & ITOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | LCFY | ITOC |
|---|---|---|
| Founded | 2009 | 1998 |
| Country | Australia | China |
| Employees | 18 | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.3M | 7.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | LCFY | ITOC |
|---|---|---|
| Price | $4.52 | $0.32 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 8.0K | ★ 3.0M |
| Earning Date | 05-01-2026 | 03-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.50 | $0.25 |
| 52 Week High | $13.98 | $0.65 |
Technical Indicators
Market Signals| Indicator | LCFY | ITOC |
|---|---|---|
| Relative Strength Index (RSI) | 51.51 | 47.13 |
| Support Level | $4.08 | $0.32 |
| Resistance Level | $4.80 | $0.38 |
| Average True Range (ATR) | 0.23 | 0.03 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 59.42 | 56.08 |
Price Performance
Historical ComparisonAbout LCFY Locafy Limited
Locafy Ltd is an Australian company currently focused on commercializing its Software as a Service (SaaS) online marketing technology (Technology), which prominently delivers a cost-effective location-based digital marketing solution for small businesses in the key markets of the USA, Australia and Canada. The company has two operating segments: Publishing and SEO Agency. The company derives the majority of its revenue from license subscription fees and advertising fees. Geographically, the maximum revenue is derived from North America.
About ITOC iTonic Holdings Ltd Class A Ordinary Shares
iTonic Holdings Ltd through its subsidiary, focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its product, Beijing Feitian's Treatment Planning System, helps ensure safe and effective brachytherapy using radioactive sources inside the patient to kill cancer cells and shrink tumors.